MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951. (Q27851529)

From Wikidata
Jump to navigation Jump to search
scientific article
  • MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951
edit
Language Label Description Also known as
English
MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.
scientific article
  • MGMT Promoter Methylation Is Prognostic but Not Predictive for Outcome to Adjuvant PCV Chemotherapy in Anaplastic Oligodendroglial Tumors: A Report From EORTC Brain Tumor Group Study 26951

Statements

MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951. (English)
1 reference
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
Hendrikus J Dubbink
0 references
Cathleen R van der Lee-Haarloo
0 references
Monika Hegi
0 references
Judith W M Jeuken
0 references
Ahmed Ibdaih
0 references
10 December 2009
0 references
27
0 references
35
0 references
5881-6
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit